Literature DB >> 16442928

Asymptomatic long-term survivors of coronary artery bypass surgery enjoy a quality of life equal to the general population.

Pamela J Bradshaw1, Konrad D Jamrozik, Ian S Gilfillan, Peter L Thompson.   

Abstract

BACKGROUND: Health-related quality of life (HRQOL) among long-term survivors of coronary artery bypass surgery is an important outcome that has been little studied at the population level.
METHODS: A postal survey was conducted in 1999 to 2000 in patients 6 to 20 years after coronary artery bypass graft (CABG) surgery in Western Australia. A random stratified sample of 2500 was drawn from 8910 patients who had their first CABG surgery in 1980 to 1993. Health-related quality of life was measured with Short Form 36 and EuroQol visual analogue scale.
RESULTS: Response was 82% (n = 2061). Health-related quality of life declined with age and was similar for men and women, although scores for women were worse for physical functioning. Compared with Australian population norms, the age- and sex-standardized scores of survivors of CABG were generally worse, mainly in the physical domain. Reported angina at the time of follow-up (33%), symptoms of heart failure equivalent to New York Heart Association (NYHA) classes II to IV (34%), and comorbidities such as diabetes and hypertension were associated with poorer HRQOL. For both men and women without angina or heart failure at follow-up, HRQOL was no different from that of the general population.
CONCLUSION: Overall, the quality of life among long-term survivors of CABG is worse than that of the general population, the difference being mainly attributable to recurrent symptoms and comorbidities. Quality of life for those without angina or heart failure at follow-up was equivalent to the population norms, providing an incentive to maximize efforts to abolish angina and ameliorate heart failure symptoms.

Entities:  

Mesh:

Year:  2006        PMID: 16442928     DOI: 10.1016/j.ahj.2005.04.007

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

1.  Health-related quality of life following coronary artery bypass graft surgery in post-menopausal women.

Authors:  Kenneth E Covinsky; Feng Lin; Vera Bittner; Mark A Hlatky; Sara J Knight; Eric Vittinghoff
Journal:  J Gen Intern Med       Date:  2008-06-24       Impact factor: 5.128

2.  Speed and quality in coronary artery bypass graft (CABG) surgery: is there a connection?

Authors:  Juha-Matti Lehtonen; Mikko Hippeläinen; Eija Kattainen; Juhani Kouri; Jaakko Kujala
Journal:  Health Care Manag Sci       Date:  2009-06

3.  What clinical pharmacology means to us.

Authors:  S Malhotra; N Shafiq
Journal:  Mens Sana Monogr       Date:  2006-01

4.  Health related quality of life trajectories and predictors following coronary artery bypass surgery.

Authors:  Michael R Le Grande; Peter C Elliott; Barbara M Murphy; Marian U C Worcester; Rosemary O Higgins; Christine S Ernest; Alan J Goble
Journal:  Health Qual Life Outcomes       Date:  2006-08-13       Impact factor: 3.186

5.  Effect of physical activity on the life quality of coronary artery bypass graft patients.

Authors:  M G Firouzabadi; A Sherafat; M Vafaeenasab
Journal:  J Med Life       Date:  2014-06-25

6.  Health related quality of life among myocardial infarction survivors in the United States: a propensity score matched analysis.

Authors:  Lea Mollon; Sandipan Bhattacharjee
Journal:  Health Qual Life Outcomes       Date:  2017-12-04       Impact factor: 3.186

7.  Efficacy of Neurocognitive Rehabilitation After Coronary Artery Bypass Graft Surgery in Improving Quality of Life: An Interventional Trial.

Authors:  Simin Sadat Ajtahed; Tara Rezapour; Soraya Etemadi; Hadi Moradi; Mojtaba Habibi Asgarabad; Hamed Ekhtiari
Journal:  Front Psychol       Date:  2019-08-08

8.  Number and burden of cardiovascular diseases in relation to health-related quality of life in a cross-sectional population-based cohort study.

Authors:  Therese Djärv; Anna Wikman; Pernilla Lagergren
Journal:  BMJ Open       Date:  2012-10-25       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.